Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort

Thorax. 2019 Jan;74(1):91-94. doi: 10.1136/thoraxjnl-2017-211124. Epub 2018 May 15.

Abstract

We conducted a cross-sectional analysis of baseline data from a UK cohort study which enrolled participants at risk of latent tuberculosis infection (LTBI, defined as a positive result for either of the two interferon gamma release assays). Binomial regression with a log link was used to estimate crude and adjusted prevalence ratios (PRs) and 95% CIs for the relationship between diabetes mellitus (DM) and LTBI. Adjusted for age, sex, ethnicity, body mass index and the presence of other immunocompromising conditions, DM was associated with a 15% higher prevalence of LTBI (adjusted PR=1.15, 95% CI 1.02 to 1.30, p=0.025). TRIAL REGISTRATION NUMBER: PREDICT is registered on clinicaltrials.gov (NCT01162265).

Keywords: clinical epidemiology; tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cross-Sectional Studies
  • Diabetes Mellitus / epidemiology*
  • Female
  • Humans
  • Interferon-gamma Release Tests
  • Latent Tuberculosis / diagnosis
  • Latent Tuberculosis / epidemiology*
  • Male
  • Middle Aged
  • Prevalence
  • United Kingdom / epidemiology
  • Young Adult

Associated data

  • ClinicalTrials.gov/NCT01162265